✦ LIBER ✦

Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists

✍ Scribed by Tatsuhiko Fujimoto; Jun Kunitomo; Yoshihide Tomata; Keiji Nishiyama; Masato Nakashima; Mariko Hirozane; Shin-ichi Yoshikubo; Keisuke Hirai; Shogo Marui

Book ID: 113496122
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 342 KB
Volume: 21
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.08.093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of spiropiperidine-based poten

Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists

✍ Tatsuhiko Fujimoto; Yoshihide Tomata; Jun Kunitomo; Mariko Hirozane; Shogo Marui 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 576 KB

ChemInform Abstract: Discovery of Spirop

ChemInform Abstract: Discovery of Spiropiperidine-Based Potent and Selective Orexin-2 Receptor Antagonists.

✍ Tatsuhiko Fujimoto; Yoshihide Tomata; Jun Kunitomo; Mariko Hirozane; Shogo Marui 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Discovery and Development of a New Class

Discovery and Development of a New Class of Potent, Selective, Orally Active Oxytocin Receptor Antagonists

✍ Quattropani, Anna; Dorbais, Jérôme; Covini, David; Pittet, Pierre-André; Colovra 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 444 KB

Discovery of Orally Active Prostaglandin

Discovery of Orally Active Prostaglandin D2 Receptor Antagonists.

✍ Kazuhiko Torisu; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 192 KB 👁 2 views

Discovery of cyclic guanidines as potent

Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists

✍ Christopher Sinz; Jiang Chang; Ashley Rouse Lins; Ed Brady; Mari Candelore; Qing 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 492 KB

Discovery of novel, potent, selective, a

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

✍ Dong-Ming Shen; Edward J. Brady; Mari R. Candelore; Qing Dallas-Yang; Victor D.- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 461 KB

A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzyme